ZA91534B - Vaccines - Google Patents
VaccinesInfo
- Publication number
- ZA91534B ZA91534B ZA91534A ZA91534A ZA91534B ZA 91534 B ZA91534 B ZA 91534B ZA 91534 A ZA91534 A ZA 91534A ZA 91534 A ZA91534 A ZA 91534A ZA 91534 B ZA91534 B ZA 91534B
- Authority
- ZA
- South Africa
- Prior art keywords
- vaccines
- Prior art date
Links
- 229960005486 vaccine Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
- C12N15/86—Viral vectors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10322—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
- C12N2710/00011—Details
- C12N2710/10011—Adenoviridae
- C12N2710/10311—Mastadenovirus, e.g. human or simian adenoviruses
- C12N2710/10341—Use of virus, viral particle or viral elements as a vector
- C12N2710/10343—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
- C12N2760/00011—Details
- C12N2760/20011—Rhabdoviridae
- C12N2760/20111—Lyssavirus, e.g. rabies virus
- C12N2760/20134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Virology (AREA)
- General Health & Medical Sciences (AREA)
- Biotechnology (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- Medicinal Chemistry (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Physics & Mathematics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Plant Pathology (AREA)
- Public Health (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB909001766A GB9001766D0 (en) | 1990-01-25 | 1990-01-25 | Vaccines |
Publications (1)
Publication Number | Publication Date |
---|---|
ZA91534B true ZA91534B (en) | 1991-11-27 |
Family
ID=10669925
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ZA91534A ZA91534B (en) | 1990-01-25 | 1991-01-24 | Vaccines |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0512017B1 (hu) |
JP (1) | JP3159446B2 (hu) |
KR (1) | KR920703831A (hu) |
AU (1) | AU641211B2 (hu) |
CA (1) | CA2074502C (hu) |
DE (1) | DE69126606T2 (hu) |
DK (1) | DK0512017T3 (hu) |
ES (1) | ES2103001T3 (hu) |
GB (1) | GB9001766D0 (hu) |
GR (1) | GR3024242T3 (hu) |
HU (1) | HUT65368A (hu) |
NZ (1) | NZ236887A (hu) |
WO (1) | WO1991011525A2 (hu) |
ZA (1) | ZA91534B (hu) |
Families Citing this family (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2213743T3 (es) * | 1991-04-25 | 2004-09-01 | Akzo Nobel N.V. | Vacuna de subunidad de coronavirus canino. |
US6743623B2 (en) | 1991-09-27 | 2004-06-01 | Centre National De La Recherche Scientifique | Viral recombinant vectors for expression in muscle cells |
FR2681786A1 (fr) * | 1991-09-27 | 1993-04-02 | Centre Nat Rech Scient | Vecteurs recombinants d'origine virale, leur procede d'obtention et leur utilisation pour l'expression de polypeptides dans des cellules musculaires. |
US6099831A (en) * | 1992-09-25 | 2000-08-08 | Centre National De La Recherche Scientifique | Viral recombinant vectors for expression in muscle cells |
FR2705361B1 (fr) * | 1993-05-18 | 1995-08-04 | Centre Nat Rech Scient | Vecteurs viraux et utilisation en thérapie génique. |
FR2705686B1 (fr) * | 1993-05-28 | 1995-08-18 | Transgene Sa | Nouveaux adénovirus défectifs et lignées de complémentation correspondantes. |
US5820868A (en) * | 1993-12-09 | 1998-10-13 | Veterinary Infectious Disease Organization | Recombinant protein production in bovine adenovirus expression vector system |
FR2727689A1 (fr) | 1994-12-01 | 1996-06-07 | Transgene Sa | Nouveau procede de preparation d'un vecteur viral |
JP2002512501A (ja) * | 1996-07-03 | 2002-04-23 | メリアル インコーポレイテッド | 外来性dnaを含む組換えイヌアデノウィルス(cav) |
DE69838644T2 (de) | 1997-06-23 | 2009-05-14 | The University Of Saskatchewan | Verfahren zur herstellung eines rekombinanten rinderadenovirus-vektors |
US6517843B1 (en) | 1999-08-31 | 2003-02-11 | Merial | Reduction of porcine circovirus-2 viral load with inactivated PCV-2 |
US6451319B1 (en) | 1999-04-09 | 2002-09-17 | Schering-Plough Veterinary Corporation | Recombinant and mutant adenoviruses |
AU6368901A (en) | 2000-05-31 | 2001-12-11 | Univ Saskatchewan | Modified bovine adenovirus having altered tropism |
US6916635B2 (en) | 2000-10-02 | 2005-07-12 | The Research Foundation Of State University Of New York | Hybrid adenovirus/adeno-associated virus vectors and methods of use thereof |
FR2845395B1 (fr) * | 2002-10-08 | 2008-05-30 | Agronomique Inst Nat Rech | Vecteurs adenoviraux recombinants et leurs applications |
EP1606419A1 (en) | 2003-03-18 | 2005-12-21 | Quantum Genetics Ireland Limited | Systems and methods for improving protein and milk production of dairy herds |
US7468273B2 (en) | 2003-05-01 | 2008-12-23 | Meial Limited | Canine GHRH gene, polypeptides and methods of use |
CA2545886A1 (en) | 2003-11-13 | 2005-06-02 | University Of Georgia Research Foundation, Inc. | Methods of characterizing infectious bursal disease virus |
US20050202484A1 (en) | 2004-02-19 | 2005-09-15 | The Governors Of The University Of Alberta | Leptin promoter polymorphisms and uses thereof |
CN101208104B (zh) | 2005-04-25 | 2012-10-31 | 梅瑞尔有限公司 | Nipah病毒疫苗 |
US20080241184A1 (en) | 2005-08-25 | 2008-10-02 | Jules Maarten Minke | Canine influenza vaccines |
US7771995B2 (en) | 2005-11-14 | 2010-08-10 | Merial Limited | Plasmid encoding human BMP-7 |
CA2629522A1 (en) | 2005-11-14 | 2007-05-18 | Merial Limited | Gene therapy for renal failure |
US7862821B2 (en) | 2006-06-01 | 2011-01-04 | Merial Limited | Recombinant vaccine against bluetongue virus |
US8202967B2 (en) | 2006-10-27 | 2012-06-19 | Boehringer Ingelheim Vetmedica, Inc. | H5 proteins, nucleic acid molecules and vectors encoding for those, and their medicinal use |
EP2414386B1 (en) | 2009-04-03 | 2016-01-27 | Merial Limited | Newcastle disease virus vectored avian vaccines |
AR078253A1 (es) | 2009-09-02 | 2011-10-26 | Boehringer Ingelheim Vetmed | Metodos para reducir la actividad antivirica en composiciones pcv-2 y composiciones pcv-2 con mejor inmunogenicidad |
US8986706B2 (en) | 2010-08-31 | 2015-03-24 | Merial, Inc. | Newcastle disease virus vectored herpesvirus vaccines |
AR083533A1 (es) | 2010-10-22 | 2013-03-06 | Boehringer Ingelheim Vetmed | Proteinas de hemaglutinina 5 (h5) para el tratamiento y prevencion de las infecciones de gripe |
WO2012090073A2 (en) | 2010-12-30 | 2012-07-05 | The Netherlands Cancer Institute | Methods and compositions for predicting chemotherapy sensitivity |
EP2694677A2 (en) | 2011-04-04 | 2014-02-12 | Netherland Cancer Institute | Methods and compositions for predicting resistance to anticancer treatment with protein kinase inhibitors |
US20140287931A1 (en) | 2011-04-04 | 2014-09-25 | Stichting Het Nederlands Kanker Instituut - Antoni Van Leeuwenhoek Ziekenhuis | Methods and compositions for predicting resistance to anticancer treatment |
WO2012145509A2 (en) | 2011-04-19 | 2012-10-26 | The Research Foundation Of State University Of New York | Adeno-associated-virus rep sequences, vectors, and viruses |
US9216213B2 (en) | 2011-04-20 | 2015-12-22 | Merial, Inc. | Adjuvanted rabies vaccine with improved viscosity profile |
AP2013007180A0 (en) | 2011-04-25 | 2013-10-31 | Advanced Bioscience Lab Inc | Truncated HIV envelope proteins (ENV), methods andcompositions related thereto |
ES2674439T3 (es) | 2011-06-01 | 2018-06-29 | Merial, Inc. | Administración sin aguja de vacunas contra el VSRRP |
CN103841963B (zh) | 2011-08-12 | 2018-04-24 | 梅里亚股份有限公司 | 用于生物产品特别是疫苗的真空辅助保存 |
AR088028A1 (es) | 2011-08-15 | 2014-05-07 | Boehringer Ingelheim Vetmed | Proteinas h5, de h5n1 para un uso medicinal |
WO2013033092A2 (en) | 2011-09-03 | 2013-03-07 | Boehringer Ingelheim Vetmedica Gmbh | Streptococcus suis pilus antigens |
WO2013093629A2 (en) | 2011-12-20 | 2013-06-27 | Netherlands Cancer Institute | Modular vaccines, methods and compositions related thereto |
WO2013138776A1 (en) | 2012-03-16 | 2013-09-19 | Merial Limited | Novel methods for providing long-term protective immunity against rabies in animals, based upon administration of replication-deficient flavivirus expressing rabies g |
WO2014127825A1 (en) | 2013-02-21 | 2014-08-28 | Boehringer Ingelheim Vetmedica Gmbh | H5 proteins of h5n1 influenza virus for use as a medicament |
EP2968514A1 (en) | 2013-03-12 | 2016-01-20 | Merial, Inc. | Reverse genetics schmallenberg virus vaccine compositions, and methods of use thereof |
AU2015241107B2 (en) | 2014-04-03 | 2019-10-03 | Boehringer Ingelheim Animal Health USA Inc. | Porcine epidemic diarrhea virus vaccine |
WO2016073410A1 (en) | 2014-11-03 | 2016-05-12 | Merial, Inc. | Methods of using microneedle vaccine formulations to elicit in animals protective immunity against rabies virus |
TWI737617B (zh) | 2015-06-23 | 2021-09-01 | 美商百靈佳殷格翰動物保健美國有限公司 | 含prrsv微量蛋白之重組病毒載體及其製造方法與用途 |
MX2017016252A (es) | 2015-08-31 | 2018-04-20 | Boehringer Ingelheim Vetmedica Gmbh | Vacunas de pestivirus para temblores congenitos. |
JP2018526454A (ja) | 2015-09-16 | 2018-09-13 | ベーリンガー インゲルハイム フェトメディカ インコーポレイテッド | ブタコレラ菌−ネズミチフス菌ワクチン |
AR109540A1 (es) | 2016-09-20 | 2018-12-19 | Boehringer Ingelheim Vetmedica Gmbh | Moléculas promotoras para expresar antígenos virales |
EP3515504B1 (en) | 2016-09-20 | 2023-07-12 | Boehringer Ingelheim Vetmedica GmbH | Canine adenovirus vectors |
EA201990711A1 (ru) | 2016-09-20 | 2019-09-30 | Бёрингер Ингельхайм Ветмедика Гмбх | Новый ehv сайт инсерции orf70 |
TW201823465A (zh) | 2016-09-20 | 2018-07-01 | 德商百靈佳殷格翰維美迪加股份有限公司 | 新穎豬流感疫苗 |
US10485866B2 (en) | 2016-11-03 | 2019-11-26 | Boehringer Ingelheim Vetmedica Gmbh | Vaccine against porcine parvovirus |
EA201991041A1 (ru) | 2016-11-03 | 2019-11-29 | Вакцина против свиного парвовируса и вируса свиного репродуктивного и респираторного синдрома и способы ее получения | |
CA3046684A1 (en) | 2017-01-30 | 2018-08-02 | Boehringer Ingelheim Animal Health USA Inc. | Porcine coronavirus vaccines |
JP7083362B2 (ja) | 2017-07-12 | 2022-06-10 | ベーリンガー インゲルハイム アニマル ヘルス ユーエスエイ インコーポレイテッド | セネカウイルスa免疫原性組成物およびその方法 |
WO2019057859A1 (en) | 2017-09-23 | 2019-03-28 | Boehringer Ingelheim Vetmedica Gmbh | EXPRESSION SYSTEM OF PARAMYXOVIRIDAE |
WO2019092027A1 (en) | 2017-11-09 | 2019-05-16 | Boehringer Ingelheim Vetmedica Gmbh | Sapelovirus immunogenic compositions and uses thereof |
TW201942355A (zh) | 2018-02-23 | 2019-11-01 | 德商百靈佳殷格翰維美迪加股份有限公司 | 表現外源貓副黏液病毒基因之重組病毒載體系統及自其製備之疫苗 |
WO2019179966A1 (en) | 2018-03-19 | 2019-09-26 | Boehringer Ingelheim Vetmedica Gmbh | Ehv insertion site ul43 |
CN111867625B (zh) | 2018-03-19 | 2024-09-17 | 勃林格殷格翰动物保健有限公司 | 具有失活ul18和/或ul8的新ehv |
CN112088013A (zh) | 2018-03-26 | 2020-12-15 | 勃林格殷格翰动物保健美国有限公司 | 制备免疫原性组合物的方法 |
KR20210062015A (ko) | 2018-09-20 | 2021-05-28 | 베링거잉겔하임베트메디카게엠베하 | 변형된 pedv 스파이크 단백질 |
CN112867506A (zh) | 2018-09-20 | 2021-05-28 | 勃林格殷格翰动物保健有限公司 | 抗猪流行性腹泻的鼻内载体疫苗 |
JP2023513135A (ja) | 2020-02-06 | 2023-03-30 | ベーリンガー インゲルハイム フェトメディカ ゲーエムベーハー | 抗ラブドウイルス抗体を検出するのに有用なポリペプチド |
EP4225361A1 (en) | 2020-10-05 | 2023-08-16 | Boehringer Ingelheim Animal Health USA Inc. | Fusion protein comprising circoviridae capsid protein, and chimeric virus-like particles composed thereof |
EP4225776A1 (en) | 2020-10-05 | 2023-08-16 | Boehringer Ingelheim Vetmedica GmbH | Fusion protein useful for vaccination against rotavirus |
AR128992A1 (es) | 2022-04-05 | 2024-07-03 | Boehringer Ingelheim Vetmedica Gmbh | Composición inmunógena útil para la vacunación contra el rotavirus |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU576907B2 (en) * | 1984-11-01 | 1988-09-08 | American Home Products Corporation | Oral vaccines comprising live recombinant adenoviruses |
-
1990
- 1990-01-25 GB GB909001766A patent/GB9001766D0/en active Pending
-
1991
- 1991-01-24 ZA ZA91534A patent/ZA91534B/xx unknown
- 1991-01-24 NZ NZ236887A patent/NZ236887A/en unknown
- 1991-01-25 DE DE69126606T patent/DE69126606T2/de not_active Expired - Fee Related
- 1991-01-25 WO PCT/GB1991/000107 patent/WO1991011525A2/en active IP Right Grant
- 1991-01-25 HU HU9202436A patent/HUT65368A/hu unknown
- 1991-01-25 JP JP50313991A patent/JP3159446B2/ja not_active Expired - Fee Related
- 1991-01-25 KR KR1019920701760A patent/KR920703831A/ko not_active Application Discontinuation
- 1991-01-25 CA CA002074502A patent/CA2074502C/en not_active Expired - Fee Related
- 1991-01-25 ES ES91903143T patent/ES2103001T3/es not_active Expired - Lifetime
- 1991-01-25 AU AU70756/91A patent/AU641211B2/en not_active Ceased
- 1991-01-25 EP EP91903143A patent/EP0512017B1/en not_active Expired - Lifetime
- 1991-01-25 DK DK91903143.5T patent/DK0512017T3/da active
-
1997
- 1997-07-25 GR GR970401882T patent/GR3024242T3/el unknown
Also Published As
Publication number | Publication date |
---|---|
GR3024242T3 (en) | 1997-10-31 |
WO1991011525A2 (en) | 1991-08-08 |
KR920703831A (ko) | 1992-12-18 |
ES2103001T3 (es) | 1997-08-16 |
JP3159446B2 (ja) | 2001-04-23 |
DK0512017T3 (da) | 1998-01-19 |
EP0512017A1 (en) | 1992-11-11 |
DE69126606T2 (de) | 1998-01-08 |
HU9202436D0 (en) | 1992-12-28 |
GB9001766D0 (en) | 1990-03-28 |
AU641211B2 (en) | 1993-09-16 |
JPH05505306A (ja) | 1993-08-12 |
WO1991011525A3 (en) | 1991-09-05 |
HUT65368A (en) | 1994-05-02 |
CA2074502C (en) | 2001-07-17 |
EP0512017B1 (en) | 1997-06-18 |
NZ236887A (en) | 1992-04-28 |
AU7075691A (en) | 1991-08-21 |
DE69126606D1 (de) | 1997-07-24 |
CA2074502A1 (en) | 1991-07-26 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA91534B (en) | Vaccines | |
AP9300541A0 (en) | Vaccines | |
AP9300530A0 (en) | Vaccines | |
GB9105992D0 (en) | Vaccine | |
IL99899A0 (en) | Vaccines | |
GB8921470D0 (en) | Vaccines | |
HU912864D0 (en) | Haemophylus paragallinarum vaccine | |
GB9215233D0 (en) | Vaccines | |
ZA93919B (en) | Vaccines | |
GB9213559D0 (en) | Vaccines | |
GB9214871D0 (en) | Vaccines | |
GB9201023D0 (en) | Vaccines | |
GB8912496D0 (en) | Vaccines | |
GB9226768D0 (en) | Vaccines | |
GB9011358D0 (en) | Vaccines | |
GB9006097D0 (en) | Vaccines | |
GB9020584D0 (en) | Vaccine | |
GB9021004D0 (en) | Acellular vaccines | |
GB9211081D0 (en) | Vaccines | |
ZA928770B (en) | Vaccines | |
GB9121208D0 (en) | Vaccines | |
GB9119167D0 (en) | Vaccines | |
GB9119009D0 (en) | Vaccines | |
GB9110067D0 (en) | Vaccines | |
GB9105993D0 (en) | Vaccines |